GlassScriptPhysician profile
Patrick M Mcdonald
NPI 1215284815
$3,578.22
in general payments reported to CMS, 2019-2025
16 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Community Health (Nurse Practitioner) provider received nationally (typical 2025 total: $139).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $738 · 2022: $1,097 · 2023: $956 · 2024: $672 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,742.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $482.48 | 2021-2024 | Rexulti, Abilify Maintena |
| Neurocrine Biosciences, INC. | $434.36 | 2021-2025 | Ingrezza |
| Alkermes, INC. | $370.04 | 2021-2024 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $327.20 | 2021-2025 | Caplyta |
| Supernus Pharmaceuticals, INC. | $300.54 | 2021-2025 | Qelbree, Qelbree |
| Sunovion Pharmaceuticals INC. | $287.56 | 2021-2022 | |
| Abbvie INC. | $267.42 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $213.06 | 2022-2024 | Fanapt, Hetlioz |
| Ironshore Pharmaceuticals INC. | $185.09 | 2021-2024 | Jornay Pm |
| Tris Pharma INC | $176.05 | 2024-2025 | Dyanavel Xr, Onyda Xr |
| Lundbeck LLC | $170.45 | 2021-2024 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $162.80 | 2022-2024 | Austedo, Austedo Xr, Uzedy |
| Takeda Pharmaceuticals U.S.A., INC. | $132.09 | 2021-2022 | |
| Axsome Therapeutics, INC. | $40.67 | 2022-2023 | Auvelity |
| Adlon Therapeutics L.P. | $14.84 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $13.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.